Pew Comments on Discussion Draft of VALID Act to Update In Vitro Diagnostics Regulations

Pew Comments on Discussion Draft of VALID Act to Update In Vitro Diagnostics Regulations

In February 2019, The Pew Charitable Trusts offered comments on the discussion draft of the Verifying Accurate Leading-edge IVCT Development (VALID) Act, a bill that would update how diagnostic tests involving human samples, known as in vitro diagnostics (IVDs), are regulated. IVDs play an important role in health care, with providers and patients relying on them to provide accurate information to inform their decisions. But as technology has advanced and the way providers use diagnostic tests has evolved, the oversight scheme for them has not kept up. Though many details have yet to be resolved, the VALID Act draft represents an important step in the broader effort to reform this outdated system. This act reflects a set of principles that Pew believes should be part of any updates to IVD regulations, in order to ensure patient safety while enabling innovative tests to come to market expeditiously.

National Homeownership Month

Article

37 Researchers Working to Transform Biomedical Science

Quick View
Article

Biomedical researchers are on the front lines of scientific innovation. From responding to global pandemics to pioneering lifesaving cancer treatments, these researchers push past scientific boundaries to solve pressing health challenges. For nearly 40 years, The Pew Charitable Trusts has supported more than 1,000 early-career biomedical scientists committed to this discovery.

Composite image of modern city network communication concept

Learn the Basics of Broadband from Our Limited Series

Sign up for our four-week email course on Broadband Basics

Quick View

How does broadband internet reach our homes, phones, and tablets? What kind of infrastructure connects us all together? What are the major barriers to broadband access for American communities?

Pills illustration
Pills illustration

What Is Antibiotic Resistance—and How Can We Fight It?

Sign up for our four-week email series The Race Against Resistance.

Quick View

Antibiotic-resistant bacteria, also known as “superbugs,” are a major threat to modern medicine. But how does resistance work, and what can we do to slow the spread? Read personal stories, expert accounts, and more for the answers to those questions in our four-week email series: Slowing Superbugs.